Home > Journals > Indian Journal of Cancer Education and Research

Indian Journal of Cancer Education and Research

Submit your article Read this Journals View all journals
Full Text (PDF)
Review Article

US-FDA Approved Chemotherapy Drugs in 2014

Muhasaparur Ganesan Rajanandh2 , Anita Ramesh1 , Muhasaparur Ganesan Rajanandh2

Author Information

Licence:



Indian Journal of Cancer Education and Research 3(1):p 27-29, Jan-Jun 2015. | DOI: DOI: https://dx.doi.org/10.21088/ijcer.2321.9815.3115.4

How Cite This Article:

Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Cancer is a disease characterized by uncontrolled proliferation of cells. Cancer occurs when the genetic information of the cell i.e. DNA is somehow damaged, with that result the cell begins to multiply uncontrollable, irreversible, independent, autonomous, uncoordinated and relatively unlimited and abnormal overgrowth of tissues. The management of any cancer mainly depends on the type and stage of the cancer followed by patients’ age, health and economic status. Cancer patients generally require combination therapy and palliative care. There is no single treatment for any type of cancer. Treatments such as surgery, radiation, chemotherapy, hormone therapy and immunotherapy or gene therapy are routinely used. Among them chemotherapy is the universal treatment option which uses drugs to destroy the cancer cells. This paper summarize the recently FDA approved drugs for the treatment of cancer. 
 
Key words: Cancer; US-FDA; Chemotherapy.

References

No records found.


About this article

Cite this article

Licence:



Received Accepted Published
N/A N/A N/A
DOI: DOI: https://dx.doi.org/10.21088/ijcer.2321.9815.3115.4

Keywords


Article Level Metrics

Last Updated

Friday 31 July 2026, 15:24:46 (IST)

1318

Accesses

5
266
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received N/A
Accepted N/A
Published N/A

licence




Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share